SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 89 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,297 | +55.4% | 2,577 | +65.0% | 0.00% | 0.0% |
| Q2 2023 | $11,777 | -50.8% | 1,562 | -15.9% | 0.00% | 0.0% |
| Q1 2022 | $23,950 | -87.5% | 1,858 | -75.8% | 0.00% | -66.7% |
| Q4 2021 | $191,020 | -24.8% | 7,690 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $253,924 | +14.3% | 7,690 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $222,241 | -38.5% | 7,690 | +7.8% | 0.00% | -40.0% |
| Q1 2021 | $361,510 | +0.5% | 7,136 | -3.7% | 0.01% | 0.0% |
| Q4 2020 | $359,704 | +223.0% | 7,412 | +17.7% | 0.01% | +150.0% |
| Q3 2020 | $111,359 | -2.9% | 6,295 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $114,632 | +50.4% | 6,295 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $76,232 | -16.6% | 6,295 | +9.3% | 0.00% | 0.0% |
| Q2 2019 | $91,385 | -15.6% | 5,762 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $108,268 | – | 5,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |